1 |
आयुष मंत्रालय Ministry of AYUSH |
image |
2 |
Home |
text |
3 |
Awareness |
text |
4 |
- |
image |
5 |
ncov2019@gov.in |
text |
6 |
(a) NATUROPATHY Guidelines |
text |
7 |
(b) SIDDHA Guidelines |
text |
8 |
(c) HOMOEOPATHIC Guidelines |
text |
9 |
(d) UNANI Guidelines |
text |
10 |
(e) AYURVEDA Guidelines |
text |
11 |
(f) YOGA Guidelines |
text |
12 |
Clinical Protocol Guideline |
text |
13 |
(a) Guidelines of Clinical Evaluation |
text |
14 |
(b) Guidelines of Drug Development |
text |
15 |
(c) Guidelines of Safety Toxicity |
text |
16 |
Notification for undertaking research on Covid 19 through Ayurveda, Unani, Siddha and Homoeopathy systems |
text |
17 |
Rejoinder issued to the New York Times for correct representation of facts about Government of India's approach to adopting AYUSH solutions during the Covid- 19 crisis |
text |
18 |
ADVISORY FROM MINISTRY OF AYUSH FOR MEETING THE CHALLENGE ARISING OUT OF SPREAD OF CORONA VIRUS (COVID-19) IN INDIA |
text |
19 |
Telemedicine Practices Guidelines by CCIM |
text |
20 |
Telemedicine Practice Guidelines by CCH |
text |
21 |
Training resources for Covid 19 Management |
text |
22 |
Ayurveda’s immunity boosting measures for self care during COVID 19 crisis |
text |
23 |
Order to stop and prevent publicity and advertis*****t of AYUSH-related claims for COVID-19 treatment |
text |
24 |
Expediting the process for grant of approval-license-renewal of license for manufacturing of ASU immunity boosting healthcare products and sanitizers |
text |